15 episodes

Interviews and highlights from the 2017 International Forum on Cancer Patients Empowerment in Milan, Italy.

IFCPE 2017 ecancer

    • Medicine

Interviews and highlights from the 2017 International Forum on Cancer Patients Empowerment in Milan, Italy.

    • video
    The European Alliance for Personalised Medicine

    The European Alliance for Personalised Medicine

    Denis Horgan talks to ecancer at IFCPE 2017 about the European Alliance for Personalised Medicine and looking to integrate innovation into healthcare and patient empowerment.

    Denis goes on to discuss the guidelines outlined by the European Alliance for Personalised Medicine and how these guidelines can drive innovation into healthcare systems.

    • 4 min
    • video
    Aromatase gene amplification

    Aromatase gene amplification

    Dr Pruneri talks to ecancer at IFCPE 2017 about a clinical trial looking at the prevalence of the aromatase gene amplification.

    • 3 min
    • video
    EUPATI and patient involvement

    EUPATI and patient involvement

    Paola Kruger talks to ecancer at IFCPE 2017 about what patients can do to be more involved in their own therapy options and how the patients input can be valuable within a clinical trial.

    She discusses the importance of patients creating a community, allowing patients to connect, share information and support each other throughout their care.

    • 6 min
    • video
    European guidelines for breast cancer treatment

    European guidelines for breast cancer treatment

    Dr Nicholl talks to ecancer at IFCPE 2017 outlining the constantly updating guidelines for breast cancer screening and diagnosis.

    By updating practice and clinical guidelines regularly, Dr Nicholl highlights better quality assurance and closer personalisation of care, so that fewer patients fall between the cracks.

    These guidelines follow mapping of all breast cancer services in the EU to establish a scheme that fits a wide range of resource availability.

    • 6 min
    • video
    Improving outcomes for oestrogen receptor positive breast cancer

    Improving outcomes for oestrogen receptor positive breast cancer

    Dr Pruneri talks to ecancer at IFCPE 2017 about treating the 20% of oestrogen-receptor positive breast cancer patients who relapse following first-line treatments.

    He describes how comparative genotyping of primary tumours and subsequent lesions could reveal treatment resistance, giving the example of recent research exposing aromatase inhibitor resistance.

    • 8 min
    • video
    The recent past and near future of drug approvals in Europe

    The recent past and near future of drug approvals in Europe

    Prof de Braud talks to ecancer at IFCPE 2017 about the development of new drugs since 2013 and how these new drugs have improved patients care and quality of life.

    • 7 min

Top Podcasts In Medicine

More by ecancer